MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-3377
Full Text
Open PDFAbstract
Available in full text
Date
May 14, 2015
Authors
Publisher
American Association for Cancer Research (AACR)